-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on FibroBiologics, Maintains $5 Price Target

Benzinga·01/02/2026 11:13:47
Listen to the news
HC Wainwright & Co. analyst Matthew Caufield reiterates FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $5 price target.